Romanian adaptation of the 6-item Hypomanic Personality Scale (HPS-6)
Official title: Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian.
Run by Babes-Bolyai University · NCT07399626 · Data updated 2026-11-12
This project will test the six-item Hypomanic Personality Scale in Romanian-speaking adults to see if it reliably screens for hypomanic traits.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Babes-Bolyai University Academic / other |
| Locations | 1 site (Cluj-Napoca) |
| Status | Recruiting |
| Started | September 22, 2025 |
| Main results expected | May 2026 |
| Study ends | July 2026 |
| Registry record updated | February 10, 2026 |
| Trial ID | NCT07399626 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are native Romanian speakers aged 18–50 with intact reading comprehension who are not currently at high suicide risk or experiencing active substance or alcohol use disorders.
✕Probably not a fit
People outside the 18–50 age range, non-native Romanian speakers, those with current high suicide risk, active SUD/AUD, or significant cognitive impairment are unlikely to benefit from this screening validation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project will translate and culturally adapt the HPS-6 into Romanian and administer it to native Romanian-speaking adults aged 18–50 at Babeș-Bolyai University. Eligible participants without current high suicide risk or active substance use will complete the HPS-6 and related questionnaires. Psychometric analyses will evaluate internal consistency, factor structure, and screening accuracy against clinical indicators. The goal is to create a brief, validated screening tool usable in Romanian clinical and community settings.
Why it matters
Potential benefit: If successful, this could provide a quick, culturally appropriate screening tool to help identify people at risk for bipolar disorder earlier and guide timely referral.
How similar studies have gone: Short versions of the Hypomanic Personality Scale and related hypomania screening tools have been validated in other countries and generally show acceptable reliability and screening performance.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-50 years of age * Not at high risk of suicide (current) * Not high SUDs / AUDs (current) * Native Romanian speaker * Cognitive abilities intact (reading comprehension of items) Exclusion Criteria: * High risk of suicide (current) * High SUDs / AUDs (current)
Where it's running
-
Babeș-Bolyai University
Cluj-Napoca, Romania Recruiting
Study contacts
- Study coordinator: Renata Gheorghiu, PhD Student
- Email: renata.gheorghiu@ubbcluj.ro
- Phone: Romania: 0731 739 485
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
-
Predicting Treatment Response in Psychiatric Disorders Using Biological Markers
This study tests whether biological markers can predict which patients with psychiatric conditions will respond to treatment.
-
Customized brain stimulation to help mood in bipolar disorder
This study tests whether personalized, non-invasive brain stimulation with rTMS can help people with bipolar depression see if their mood shifts toward euthymia.
-
Pramipexole adds on to mood stabilizers for bipolar depression
This trial tests whether adding pramipexole to standard mood-stabilizing treatment helps reduce anhedonia in adults with bipolar depression compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.